Global Gastrointestinal Drugs Market Research Report 2023

Global Gastrointestinal Drugs Market Research Report 2023

Table of Contents
1 Gastrointestinal Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Gastrointestinal Drugs Segment by Type
1.2.1 Global Gastrointestinal Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Gastrointestinal Drugs Segment by Application
1.3.1 Global Gastrointestinal Drugs Market Value by Application: (2023-2029)
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastrointestinal Drugs Revenue 2018-2029
1.4.2 Global Gastrointestinal Drugs Sales 2018-2029
1.4.3 Global Gastrointestinal Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gastrointestinal Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gastrointestinal Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Gastrointestinal Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastrointestinal Drugs, Product Type & Application
2.7 Gastrointestinal Drugs Market Competitive Situation and Trends
2.7.1 Gastrointestinal Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gastrointestinal Drugs Players Market Share by Revenue
2.7.3 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastrointestinal Drugs Retrospective Market Scenario by Region
3.1 Global Gastrointestinal Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gastrointestinal Drugs Global Gastrointestinal Drugs Sales by Region: 2018-2029
3.2.1 Global Gastrointestinal Drugs Sales by Region: 2018-2023
3.2.2 Global Gastrointestinal Drugs Sales by Region: 2024-2029
3.3 Global Gastrointestinal Drugs Global Gastrointestinal Drugs Revenue by Region: 2018-2029
3.3.1 Global Gastrointestinal Drugs Revenue by Region: 2018-2023
3.3.2 Global Gastrointestinal Drugs Revenue by Region: 2024-2029
3.4 North America Gastrointestinal Drugs Market Facts & Figures by Country
3.4.1 North America Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gastrointestinal Drugs Sales by Country (2018-2029)
3.4.3 North America Gastrointestinal Drugs Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Gastrointestinal Drugs Market Facts & Figures by Country
3.5.1 Europe Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gastrointestinal Drugs Sales by Country (2018-2029)
3.5.3 Europe Gastrointestinal Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gastrointestinal Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Gastrointestinal Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gastrointestinal Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gastrointestinal Drugs Sales by Country (2018-2029)
3.7.3 Latin America Gastrointestinal Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gastrointestinal Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gastrointestinal Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastrointestinal Drugs Sales by Type (2018-2029)
4.1.1 Global Gastrointestinal Drugs Sales by Type (2018-2023)
4.1.2 Global Gastrointestinal Drugs Sales by Type (2024-2029)
4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029)
4.2 Global Gastrointestinal Drugs Revenue by Type (2018-2029)
4.2.1 Global Gastrointestinal Drugs Revenue by Type (2018-2023)
4.2.2 Global Gastrointestinal Drugs Revenue by Type (2024-2029)
4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Gastrointestinal Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gastrointestinal Drugs Sales by Application (2018-2029)
5.1.1 Global Gastrointestinal Drugs Sales by Application (2018-2023)
5.1.2 Global Gastrointestinal Drugs Sales by Application (2024-2029)
5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029)
5.2 Global Gastrointestinal Drugs Revenue by Application (2018-2029)
5.2.1 Global Gastrointestinal Drugs Revenue by Application (2018-2023)
5.2.2 Global Gastrointestinal Drugs Revenue by Application (2024-2029)
5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Gastrointestinal Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Gastrointestinal Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Gastrointestinal Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer Gastrointestinal Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Gastrointestinal Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Gastrointestinal Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Zeria (Tillotts)
6.6.1 Zeria (Tillotts) Corporation Information
6.6.2 Zeria (Tillotts) Description and Business Overview
6.6.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
6.7.5 Zeria (Tillotts) Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Corporation Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Perrigo Gastrointestinal Drugs Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Purdue Pharma
6.10.1 Purdue Pharma Corporation Information
6.10.2 Purdue Pharma Description and Business Overview
6.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Purdue Pharma Gastrointestinal Drugs Product Portfolio
6.10.5 Purdue Pharma Recent Developments/Updates
6.11 C.B. Fleet
6.11.1 C.B. Fleet Corporation Information
6.11.2 C.B. Fleet Gastrointestinal Drugs Description and Business Overview
6.11.3 C.B. Fleet Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 C.B. Fleet Gastrointestinal Drugs Product Portfolio
6.11.5 C.B. Fleet Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Gastrointestinal Drugs Description and Business Overview
6.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Abbott Gastrointestinal Drugs Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Jiangzhong
6.13.1 Jiangzhong Corporation Information
6.13.2 Jiangzhong Gastrointestinal Drugs Description and Business Overview
6.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jiangzhong Gastrointestinal Drugs Product Portfolio
6.13.5 Jiangzhong Recent Developments/Updates
6.14 Xian-Janssen
6.14.1 Xian-Janssen Corporation Information
6.14.2 Xian-Janssen Gastrointestinal Drugs Description and Business Overview
6.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Xian-Janssen Gastrointestinal Drugs Product Portfolio
6.14.5 Xian-Janssen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastrointestinal Drugs Industry Chain Analysis
7.2 Gastrointestinal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastrointestinal Drugs Production Mode & Process
7.4 Gastrointestinal Drugs Sales and Marketing
7.4.1 Gastrointestinal Drugs Sales Channels
7.4.2 Gastrointestinal Drugs Distributors
7.5 Gastrointestinal Drugs Customers
8 Gastrointestinal Drugs Market Dynamics
8.1 Gastrointestinal Drugs Industry Trends
8.2 Gastrointestinal Drugs Market Drivers
8.3 Gastrointestinal Drugs Market Challenges
8.4 Gastrointestinal Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gastrointestinal Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gastrointestinal Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gastrointestinal Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gastrointestinal Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gastrointestinal Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gastrointestinal Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gastrointestinal Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Gastrointestinal Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gastrointestinal Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Gastrointestinal Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Gastrointestinal Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gastrointestinal Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gastrointestinal Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gastrointestinal Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gastrointestinal Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Gastrointestinal Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gastrointestinal Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gastrointestinal Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Gastrointestinal Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gastrointestinal Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Gastrointestinal Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Gastrointestinal Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Gastrointestinal Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gastrointestinal Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Gastrointestinal Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Gastrointestinal Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global Gastrointestinal Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Gastrointestinal Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Gastrointestinal Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Gastrointestinal Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Gastrointestinal Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gastrointestinal Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Gastrointestinal Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Gastrointestinal Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global Gastrointestinal Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. AstraZeneca Gastrointestinal Drugs Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Sanofi Gastrointestinal Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Bayer Gastrointestinal Drugs Product
Table 84. Bayer Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Pfizer Gastrointestinal Drugs Product
Table 89. Pfizer Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. GlaxoSmithKline Gastrointestinal Drugs Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Teva Gastrointestinal Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Zeria (Tillotts) Corporation Information
Table 101. Zeria (Tillotts) Description and Business Overview
Table 102. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Zeria (Tillotts) Gastrointestinal Drugs Product
Table 104. Zeria (Tillotts) Recent Developments/Updates
Table 105. Perrigo Corporation Information
Table 106. Perrigo Description and Business Overview
Table 107. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Perrigo Gastrointestinal Drugs Product
Table 109. Perrigo Recent Developments/Updates
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Boehringer Ingelheim Gastrointestinal Drugs Product
Table 114. Boehringer Ingelheim Recent Developments/Updates
Table 115. Purdue Pharma Corporation Information
Table 116. Purdue Pharma Description and Business Overview
Table 117. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Purdue Pharma Gastrointestinal Drugs Product
Table 119. Purdue Pharma Recent Developments/Updates
Table 120. C.B. Fleet Corporation Information
Table 121. C.B. Fleet Description and Business Overview
Table 122. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. C.B. Fleet Gastrointestinal Drugs Product
Table 124. C.B. Fleet Recent Developments/Updates
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Abbott Gastrointestinal Drugs Product
Table 129. Abbott Recent Developments/Updates
Table 130. Jiangzhong Corporation Information
Table 131. Jiangzhong Description and Business Overview
Table 132. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Jiangzhong Gastrointestinal Drugs Product
Table 134. Jiangzhong Recent Developments/Updates
Table 135. Xian-Janssen Corporation Information
Table 136. Xian-Janssen Description and Business Overview
Table 137. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Xian-Janssen Gastrointestinal Drugs Product
Table 139. Xian-Janssen Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Gastrointestinal Drugs Distributors List
Table 143. Gastrointestinal Drugs Customers List
Table 144. Gastrointestinal Drugs Market Trends
Table 145. Gastrointestinal Drugs Market Drivers
Table 146. Gastrointestinal Drugs Market Challenges
Table 147. Gastrointestinal Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gastrointestinal Drugs
Figure 2. Global Gastrointestinal Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gastrointestinal Drugs Market Share by Type in 2022 & 2029
Figure 4. Prescription Gastrointestinal Drug Product Picture
Figure 5. OTC Gastrointestinal Drug Product Picture
Figure 6. Global Gastrointestinal Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Gastrointestinal Drugs Market Share by Application in 2022 & 2029
Figure 8. Chronic Gastritis
Figure 9. Functional Dyspepsia
Figure 10. Peptic Ulcer
Figure 11. Acute Gastroenteritis
Figure 12. Other
Figure 13. Global Gastrointestinal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gastrointestinal Drugs Market Size (2018-2029) & (US$ Million)
Figure 15. Global Gastrointestinal Drugs Sales (2018-2029) & (K Units)
Figure 16. Global Gastrointestinal Drugs Average Price (USD/Unit) & (2018-2029)
Figure 17. Gastrointestinal Drugs Report Years Considered
Figure 18. Gastrointestinal Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Gastrointestinal Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Gastrointestinal Drugs Players: Market Share by Revenue in 2022
Figure 21. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Gastrointestinal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 24. North America Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 25. the United States Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 28. Europe Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 29. Germany Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. UK Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2018-2029)
Figure 36. China Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 46. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Gastrointestinal Drugs Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Gastrointestinal Drugs Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Gastrointestinal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Gastrointestinal Drugs by Type (2018-2029)
Figure 56. Global Revenue Market Share of Gastrointestinal Drugs by Type (2018-2029)
Figure 57. Global Gastrointestinal Drugs Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Gastrointestinal Drugs by Application (2018-2029)
Figure 59. Global Revenue Market Share of Gastrointestinal Drugs by Application (2018-2029)
Figure 60. Global Gastrointestinal Drugs Price (USD/Unit) by Application (2018-2029)
Figure 61. Gastrointestinal Drugs Value Chain
Figure 62. Gastrointestinal Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs